Ischemic Heart Disease Congestive Heart Failure Chronic Kidney Disease Peripheral arterial Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients who are scheduled for cardiovascular angiography including diagnostic coronary angiography, ventriculography, aortography, and/or coronary or peripheral intervention.
Exclusion criteria
Exclusion criteria: peritoneal dialysis, hemodialysis treatment, cardiogenic shock, congestive heart failure, pregnancy, a history of severe allergies to contrast media, recent major bleeding, having a metformin within 48 hours of the study entry, chronic obstructive pulmonary disease, patient with the oxygen saturation lesser than 90 percent, acute coronary syndrome, severe infection, severe malnutrition, post-operative states, pituitary or adrenal dysfunction, paraquat intoxication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Contrast-Induced Nephropathy : defined as an increase in the serum creatinine concentration of 25 percent or 0.5 mg/dl from the baseline at maximum value obtained within 48 hours after the procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| sex, age (more than 70-year-old), hypertension, diabetes mellitus, dyslipidemia, a history of myocardial infarction, BNP(more than 100pg/ml), anemia, use of ACE inhibitors/ARBs, use of diuretics, use of statins, use of contast-medium (more than 150ml), eGFR (less than 60ml/min/1.73m2), PaO2 (more than 100 mmHg) As sub-analysis, among the patients with eGFR under 60ml/min/1.73m2 for CIN high risk group. | — |
Countries
Japan